Nashville is Home to Susan G. Komen® Chief Scientific Advisor 

Meet Dr. Jennifer Pietenpol, Susan G. Komen® Chief Scientific Advisor, Nashville Resident and Director of Vanderbilt-Ingram Cancer Center. Jennifer also serves as the Executive Vice President for Research at Vanderbilt University Medical Center, the B.F. Byrd Jr. Professor of Molecular Oncology, and Professor of Biochemistry and  Otolaryngology at Vanderbilt University School of Medicine.

The Scientific Advisory Board (SAB) provides strategic guidance and direction for Komen’s research and scientific programs. It plays a key role in guiding and prioritizing Komen’s global research investment and serves as the executive committee for the Komen Scholars. The SAB is led by the chief scientific advisors and is comprised of leaders in breast cancer research, clinical practice and advocacy who have made significant contributions to advancing the field and are committed to furthering Komen’s mission. 

Dr. Pietenpol’s early research focused on the signaling of p53 family in breast cancer; p53 is a tumor suppressor gene (controls cell death) and is one of the most commonly mutated genes in cancer. More recently, Dr. Pietenpol has combined her research expertise in molecular genetics with bioinformatics to advance our knowledge of the key molecular pathways in triple negative breast cancer (TNBC). Dr. Pietenpol’s Komen funding supports research that identified molecular subtypes of TNBC and is now determining the molecular underpinnings of these distinct subtypes. The results from her laboratory-based work are being translated to several clinical trials investigating targeted therapies for TNBC patients, with the goal of helping oncologists determine the most appropriate and precise treatment for breast cancer patients.